SNOWDON
DEAD

Serial Number

78733131

Owner

Susan M. Welsh

First Use Date

Jun 24, 2008

Filing Date

Oct 14, 2005

Add to watchlist:

No watchlists yet
View on USPTO

SNOWDON Trademark

Serial Number: 78733131

SNOWDON is a trademark filed by Susan M. Welsh on October 14, 2005. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Susan M. Welsh

66 Maybury Hill Road
Princeton, NJ 08540

Entity Type: 03

Trademark Details

Filing Date

October 14, 2005

Registration Date

Not Registered

First Use Anywhere

June 24, 2008

First Use in Commerce

June 24, 2008

Published for Opposition

December 4, 2007

Goods & Services

Biological preparations for medical purposes; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Injectable pharmaceuticals for treatment of anaphylactic reactions; Ocular pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations acting on the peripheral system; Pharmaceutical preparations for pain management; Pharmaceutical preparations of immune diseases; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for use in radiation therapy to treat cancer; Pharmaceutical preparations for wounds; Pharmaceutical preparations namely, anticoagulants; Pharmaceutical preparations for the treatement of depression, anxiety, stress, and related affective diseases and disorders; Pharmaceutical preparations namely,appetite suppressants; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for chloasma; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for pregnancy blemishes; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for ophthalmological use; Pharmaceutical products for skin care for animals; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical skin lotions; Pharmaceutical solutions used in dialysis; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, anti-infectives; Pharmaceuticals, namely, antihelmintics; Pharmaceuticals, namely, inducers of erections; Pharmaceuticals, namely, lipid lowering agents; Pharmaceuticals, namely, psychotropics; Plant extracts for medical, veterinary and pharmaceutical purposes; Synthetic peptides for pharmaceutical purposes

Conducting early evaluations in the field of new pharmaceuticals; Development of new technology for others in the field of biopharmaceuticals; Development of pharmaceutical preparations and medicines; Medical and scientific research services in the field of cancer treatment and diagnosis; Medical and scientific research, namely conducting clinical trials; Medical research; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical research and development; Pharmaceutical research services; Research on the subject of pharmaceuticals; Scientific investigations for medical purposes; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff

Filing History

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Sep 23, 2010 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Sep 23, 2010 ABN2
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Feb 23, 2010 GNS1
CONTINUATION OF FINAL REFUSAL E-MAILED
Feb 23, 2010 GNCF
SU - ACTION CONTINUING FINAL - WRITTEN
Feb 23, 2010 CNCF
PETITION TO REVIVE-GRANTED
Feb 20, 2010 PETG
TEAS PETITION TO REVIVE RECEIVED
Feb 20, 2010 PROA
ABANDONMENT NOTICE MAILED - DEFECTIVE USE STATEMENT
Jan 8, 2010 MAB7
ABANDONMENT - DEFECTIVE USE STATEMENT
Jan 8, 2010 ABN7
NOTIFICATION OF FINAL REFUSAL EMAILED
Jun 2, 2009 GNFN
FINAL REFUSAL E-MAILED
Jun 2, 2009 GNFR
SU - FINAL REFUSAL - WRITTEN
Jun 2, 2009 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 27, 2009 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 27, 2009 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 25, 2009 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 28, 2009 GNRN
NON-FINAL ACTION E-MAILED
Jan 28, 2009 GNRT
SU - NON-FINAL ACTION - WRITTEN
Jan 28, 2009 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Jan 27, 2009 SUPC
USE AMENDMENT FILED
Jan 23, 2009 IUAF
TEAS STATEMENT OF USE RECEIVED
Jan 23, 2009 EISU
NOA MAILED - SOU REQUIRED FROM APPLICANT
Dec 9, 2008 NOAM
NEW NOA TO ISSUE
Oct 30, 2008 NEWN
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 30, 2008 AITU
PETITION TO REVIVE-GRANTED
Oct 30, 2008 PETG
TEAS PETITION TO REVIVE RECEIVED
Oct 30, 2008 PROA
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Oct 27, 2008 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 27, 2008 ABN6
NOTICE OF ALLOWANCE CANCELLED
Aug 26, 2008 IUCN
NOA MAILED - SOU REQUIRED FROM APPLICANT
Feb 26, 2008 NOAM
PUBLISHED FOR OPPOSITION
Dec 4, 2007 PUBO
NOTICE OF PUBLICATION
Nov 14, 2007 NPUB
WITHDRAWN FROM PUB - OG REVIEW QUERY
Oct 12, 2007 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 2, 2007 PREV
ASSIGNED TO LIE
Oct 2, 2007 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 31, 2007 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 29, 2007 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 29, 2007 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 29, 2007 TROA
NON-FINAL ACTION E-MAILED
Apr 26, 2007 GNRT
NON-FINAL ACTION WRITTEN
Apr 26, 2007 CNRT
PETITION TO REVIVE-GRANTED
Apr 11, 2007 PETG
TEAS PETITION TO REVIVE RECEIVED
Apr 11, 2007 PROA
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Mar 29, 2007 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Mar 28, 2007 ABN2
NON-FINAL ACTION E-MAILED
Aug 28, 2006 GNRT
NON-FINAL ACTION WRITTEN
Aug 28, 2006 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 18, 2006 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 16, 2006 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 16, 2006 TROA
NON-FINAL ACTION E-MAILED
Apr 25, 2006 GNRT
NON-FINAL ACTION WRITTEN
Apr 25, 2006 CNRT
ASSIGNED TO EXAMINER
Apr 19, 2006 DOCK
NEW APPLICATION ENTERED
Oct 20, 2005 NWAP